The device was returned for analysis.The reported material separation and the reported stent migration were able to be confirmed.The reported difficult to remove was unable to be replicated in a testing environment as it was based on operational circumstances.Electronic lot history record (elhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint handling database identified no other incidents from this lot.As there was no damage noted to the device during the inspection prior to use, the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that the nose cone inadvertently became caught on the deployed stent resulting in the reported difficult to remove.Interaction/manipulation of the compromised device resulted in the reported stent migration and ultimately resulted in the reported tip material separation/noted tip jacket and inner member separations and the noted mangled stent.As reported, the separated nose cone and migrated stent were removed with hemostats from the femoral artery.Based on the reported information and results of the complaint investigation there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|